Selected research
Industry Growth & Trends
Global Artesunate Medicines Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Artesunate Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Artesunate Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Artesunate Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Artesunate Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Artesunate Medicines market include Shin Poong, Sanofi Aventis, MCW Healthcare, Ipca Laboratories, Fosun Pharma (Guilin), Cipla, Ajanta Pharma and Acino, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Artesunate Medicines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Artesunate Medicines market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artesunate Medicines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artesunate Medicines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Artesunate Medicines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Artesunate Medicines Market by Company
Shin Poong
Sanofi Aventis
MCW Healthcare
Ipca Laboratories
Fosun Pharma (Guilin)
Cipla
Ajanta Pharma
Acino
Artesunate Medicines Segment by Type
Monoaromatic Artesunate
Compound Artesunate
Artesunate Medicines Segment by Application
Hospital
Clinic
Other
Artesunate Medicines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artesunate Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artesunate Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artesunate Medicines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Artesunate Medicines companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Monoaromatic Artesunate
- Compound Artesunate
Applications
- Hospital
- Clinic
- Other
Companies covered
- Shin Poong
- Sanofi Aventis
- MCW Healthcare
- Ipca Laboratories
- Fosun Pharma (Guilin)
- Cipla
- Ajanta Pharma
- Acino
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Artesunate Medicines Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Artesunate Medicines Market Size by Region (2021-2032)
- 1.4.1 Global Artesunate Medicines Market Size by Region (2021-2026)
- 1.4.2 Global Artesunate Medicines Market Size by Region (2027-2032)
- 1.5 Key Regions Artesunate Medicines Market Size (2021-2032)
- 1.5.1 North America Artesunate Medicines Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Artesunate Medicines Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Artesunate Medicines Market Size Growth Rate (2021-2032)
- 1.5.4 South America Artesunate Medicines Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Artesunate Medicines Market Size Growth Rate (2021-2032)
2 Artesunate Medicines Market by Type
- 2.1 Type Introduction
- 2.1.1 Monoaromatic Artesunate
- 2.1.2 Compound Artesunate
- 2.2 Global Artesunate Medicines Market Size by Type
- 2.2.1 Global Artesunate Medicines Market Size Overview by Type (2021-2032)
- 2.2.2 Global Artesunate Medicines Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Artesunate Medicines Market Size Forecasted by Type (2027-2032)
- 2.3 Global Artesunate Medicines Market Size by Regions
- 2.3.1 North America Artesunate Medicines Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Artesunate Medicines Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Artesunate Medicines Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Artesunate Medicines Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Artesunate Medicines Market Size Breakdown by Type (2021-2026)
3 Artesunate Medicines Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Other
- 3.2 Global Artesunate Medicines Market Size by Application
- 3.2.1 Global Artesunate Medicines Market Size Overview by Application (2021-2032)
- 3.2.2 Global Artesunate Medicines Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Artesunate Medicines Market Size Forecasted by Application (2027-2032)
- 3.3 Global Artesunate Medicines Market Size by Regions
- 3.3.1 North America Artesunate Medicines Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Artesunate Medicines Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Artesunate Medicines Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Artesunate Medicines Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Artesunate Medicines Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Artesunate Medicines Industry Trends
- 4.2 Artesunate Medicines Industry Drivers
- 4.3 Artesunate Medicines Industry Opportunities and Challenges
- 4.4 Artesunate Medicines Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Artesunate Medicines Revenue (2021-2026)
- 5.2 Global Artesunate Medicines Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Artesunate Medicines Key Company Headquarters & Area Served
- 5.4 Global Artesunate Medicines Company, Product Type & Application
- 5.5 Global Artesunate Medicines Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Artesunate Medicines Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Artesunate Medicines Players Market Share by Revenue in 2025
- 5.6.3 2025 Artesunate Medicines Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Shin Poong
- 6.1.1 Shin Poong Company Information
- 6.1.2 Shin Poong Business Overview
- 6.1.3 Shin Poong Artesunate Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Shin Poong Artesunate Medicines Product Portfolio
- 6.1.5 Shin Poong Recent Developments
- 6.2 Sanofi Aventis
- 6.2.1 Sanofi Aventis Company Information
- 6.2.2 Sanofi Aventis Business Overview
- 6.2.3 Sanofi Aventis Artesunate Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Sanofi Aventis Artesunate Medicines Product Portfolio
- 6.2.5 Sanofi Aventis Recent Developments
- 6.3 MCW Healthcare
- 6.3.1 MCW Healthcare Company Information
- 6.3.2 MCW Healthcare Business Overview
- 6.3.3 MCW Healthcare Artesunate Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 MCW Healthcare Artesunate Medicines Product Portfolio
- 6.3.5 MCW Healthcare Recent Developments
- 6.4 Ipca Laboratories
- 6.4.1 Ipca Laboratories Company Information
- 6.4.2 Ipca Laboratories Business Overview
- 6.4.3 Ipca Laboratories Artesunate Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Ipca Laboratories Artesunate Medicines Product Portfolio
- 6.4.5 Ipca Laboratories Recent Developments
- 6.5 Fosun Pharma (Guilin)
- 6.5.1 Fosun Pharma (Guilin) Company Information
- 6.5.2 Fosun Pharma (Guilin) Business Overview
- 6.5.3 Fosun Pharma (Guilin) Artesunate Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Fosun Pharma (Guilin) Artesunate Medicines Product Portfolio
- 6.5.5 Fosun Pharma (Guilin) Recent Developments
- 6.6 Cipla
- 6.6.1 Cipla Company Information
- 6.6.2 Cipla Business Overview
- 6.6.3 Cipla Artesunate Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Cipla Artesunate Medicines Product Portfolio
- 6.6.5 Cipla Recent Developments
- 6.7 Ajanta Pharma
- 6.7.1 Ajanta Pharma Company Information
- 6.7.2 Ajanta Pharma Business Overview
- 6.7.3 Ajanta Pharma Artesunate Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Ajanta Pharma Artesunate Medicines Product Portfolio
- 6.7.5 Ajanta Pharma Recent Developments
- 6.8 Acino
- 6.8.1 Acino Company Information
- 6.8.2 Acino Business Overview
- 6.8.3 Acino Artesunate Medicines Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Acino Artesunate Medicines Product Portfolio
- 6.8.5 Acino Recent Developments
7 North America
- 7.1 North America Artesunate Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Artesunate Medicines Market Size by Country (2021-2026)
- 7.3 North America Artesunate Medicines Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Artesunate Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Artesunate Medicines Market Size by Country (2021-2026)
- 8.3 Europe Artesunate Medicines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Artesunate Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Artesunate Medicines Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Artesunate Medicines Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Artesunate Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Artesunate Medicines Market Size by Country (2021-2026)
- 10.3 South America Artesunate Medicines Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Artesunate Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Artesunate Medicines Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Artesunate Medicines Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst